Recommandation pour la prise en charge d'une RTU
Traitement de la maladie de Takayasu répondant aux critères d’Ishikawa et résistant aux traitements conventionnels (corticoïdes et immunosuppresseurs
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
5NstEvTYMr6ZCLm8
